Background-The aetiology of idiopathic dilated cardiomyopathy is believed to have an immunological component. Association with human leucocyte antigens (HLAs) has been previously reported, particularly with HLA-DR4. Aim-To determine the association of HLA type with diagnosis in a group of patients assessed for heart transplantation. Methods-A comparison was made of frequencies of HLA types in patients with a diagnosis of idiopathic dilated cardiomyopathy or (n = 98) ischaemic heart disease (n = 170) and in controls from the North Western region (n = 857). Results-Neither the patients with idiopathic dilated cardiomyopathy nor those with ischaemic heart disease showed a significant increase or decrease in any HLA frequency compared with the controls. Conclusion-These results suggest that there is no HLA association with idiopathic dilated cardiomyopathy or ischaemic heart disease. This conflicts with the results of some previous studies. (Br HeartJ 1994;71:76-78) 
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(HLAs) has been previously reported, particularly with HLA-DR4. Aim-To determine the association of HLA type with diagnosis in a group of patients assessed for heart transplantation. Methods-A comparison was made of frequencies of HLA types in patients with a diagnosis of idiopathic dilated cardiomyopathy or (n = 98) ischaemic heart disease (n = 170) and in controls from the North Western region (n = 857). Results-Neither the patients with idiopathic dilated cardiomyopathy nor those with ischaemic heart disease showed a significant increase or decrease in any HLA frequency compared with the controls. Conclusion-These results suggest that there is no HLA association with idiopathic dilated cardiomyopathy or ischaemic heart disease. This conflicts with the results of some previous studies. 13 are from the same groups. The second papers from each group contain and expand on data from the earlier studies. Carlquist et al "1 also performed a meta-analysis of five of the studies.7-" Two studies"3 '4 have been published since the meta-analysis was submitted, and we have submitted most of the data presented here in abstract form,'8 as have another group who also failed to show any HLA association. 19 Various HLA associations with idiopathic dilated cardiomyopathy have been claimed including increases in frequency of DR1 and DR10 14 B7,8 DR5,'0 B27,"2, DR6, and DQ4,"1 and decreased frequency of DR3,'0 1" and DR6."2 HLA-DR4 was associated with idiopathic dilated cardiomyopathy in some of the studies7 9-3 but not in all.8 '4 The metaanalysis also seemed to confirm the association with HLA-DR4."1 A hazard of analysis of this type of data is that because of its nature many sets of comparisons are made and this increases considerably the likelihood of producing a spuriously significant association. This may partly explain the large number of different reported associations. In any case none of the reports claims an association that is as strong as in "classic" HIA linkages.
Our results do not establish any HLA linkage with idiopathic dilated cardiomyopathy or ischaemic heart disease. There is no clear reason why our series should be different from those already published, other than possible differences arising from geographically and ethnically different populations. The evidence presented in favour of a link between idiopathic dilated cardiomyopathy and HLA-DR4 is, however, inconclusive: two of the eight studies (one of which has been published since the meta-analysis) failed to show the link, and several studies have shown HIA linkages not confirmed by the others. There were 453 patients in these studies7-'4 and 361 were included in the metaanalysis. Much more data than these must be available: 19 451 heart transplants had been performed worldwide by 31 December 199120; most of these will have been HLA typed together with a substantial number of patients who were assessed but did not receive transplants. Forty nine per cent of heart transplants are performed for cardiomyopathy,20 and most of these patients will have idiopathic dilated cardiomyopathy. Thus there must be much unpublished data on HIA typing in this condition. This information will be concentrated in transplant centres where comprehensive dayabases are usually maintained. It may well be, therefore, that other researchers have also failed to show the association but have not considered it worth reporting or have encountered publication bias against negative results.
We also found no association between HIA type and end stage coronary heart disease, but this is less controversial because so far immunological mechanisms have not been implicated in the native disease and only one study to date has suggested a link (with HIA-DR6). 15 An immunological basis for idiopathic dilated cardiomyopathy remains likely, but idiopathic dilated cardiomyopathy is probably a heterogeneous condition and it may be that a strong immunological component is not a feature of all subgroups.
